evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract
15381,GENE_BACKGROUND,,"The NF1 gene encodes a GTPase activating protein (GAP) for the small GTPases HRAS, KRAS and NRAS (PMID: 2121370,1946382). When bound to RAS, the NF1 protein stabilizes the GTPase activity of the RAS proteins, which switches RAS from its active, GTP-bound state to its inactive, GDP-bound state (PMID: 9219684, 9302992). The GAP-related domain (GRD) is the catalytic domain of NF1, which is directly responsible for its GAP activity but only encompasses approximately 10% of the protein. NF1 is congenitally altered in the cancer-predisposing syndrome Neurofibromatosis Type 1 and is somatically altered in many tumor types including breast cancer, melanoma, and glioma (PMID: 2134734, 1946382, 18772890, 23000897, 9639526, 18948947, 22817889). Inactivation of NF1 due to gene deletion, gene mutation, or protein degradation results in elevated levels of active, GTP-bound RAS and activation of downstream pathways such as the MAPK/ERK pathway and the PI3K pathway (PMID: 19573811, 24576830, 8563751, 7542586, 8052307, 12509763). Missense and truncating mutations occur across the entire gene and do not localize to hotspots. Alterations occurring on one allele of NF1 likely lead to haploinsufficiency of the protein (PMID: 7920653,18089636) as many patients with Neurofibromatosis Type 1 have an unaltered second allele despite exhibiting symptoms of the syndrome. Additionally, functional loss of heterozygosity likely occurs on the second NF1 allele, as tumors with NF1 point mutations have lower levels of mRNA than wildtype tumors (cBioPortal, MSKCC, May 2015).",,2017-04-27,,4763,NF1,neurofibromin 1,False,ENST00000358273,NM_001042492.2,WSS,NFNS,VRNF,True,8563751,Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.,Nature genetics,0001-02-01,12,2,144-8,Bollag G et al,,,0001-02-01,,2134734,Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.,"Science (New York, N.Y.)",0001-07-13,249,4965,181-6,Wallace MR et al,,,0001-07-13,,1946382,Identification of the neurofibromatosis type 1 gene product.,Proceedings of the National Academy of Sciences of the United States of America,0001-11-01,88,21,9658-62,Gutmann DH et al,,,0001-11-01,,18772890,Comprehensive genomic characterization defines human glioblastoma genes and core pathways.,Nature,2018-10-23T20:08:00,455,7216,1061-8,Cancer Genome Atlas Research Network.,doi: 10.1038/nature07385,,0001-10-23,,7542586,Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.,The EMBO journal,0001-07-03,14,13,3136-45,Marais R et al,,,0001-07-03,,9639526,"Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.",Blood,0001-07-01,92,True,267-72,Side LE et al,,,0001-07-01,,7920653,Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.,Nature genetics,0001-07-01,7,3,353-61,Jacks T et al,,,0001-07-01,,8052307,Phosphatidylinositol-3-OH kinase as a direct target of Ras.,Nature,0001-08-18,370,6490,527-32,Rodriguez-Viciana P et al,,,0001-08-18,,22817889,A landscape of driver mutations in melanoma.,Cell,2018-07-20T20:12:00,150,2,251-63,Hodis E et al,doi: 10.1016/j.cell.2012.06.024,,0001-07-20,,23000897,Comprehensive molecular portraits of human breast tumours.,Nature,2018-10-04T20:12:00,490,7418,61-70,Cancer Genome Atlas Network.,doi: 10.1038/nature11412,,0001-10-04,,9219684,The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.,"Science (New York, N.Y.)",0001-07-18,277,5324,333-8,Scheffzek K et al,,,0001-07-18,,19573811,Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.,Cancer cell,2018-07-07T20:09:00,16,True,44-54,McGillicuddy LT et al,doi: 10.1016/j.ccr.2009.05.009,,0001-07-07,,24576830,Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.,Cancer research,2018-04-15T20:14:00,74,8,2340-50,Nissan MH et al,doi: 10.1158/0008-5472.CAN-13-2625,,0001-04-15,,18948947,Somatic mutations affect key pathways in lung adenocarcinoma.,Nature,2018-10-23T20:08:00,455,7216,1069-75,Ding L et al,doi: 10.1038/nature07423,,0001-10-23,,18089636,Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1.,Human molecular genetics,2018-04-01T20:08:00,17,7,936-48,Yan J et al,,,0001-04-01,,9302992,Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras.,Nature structural biology,0001-09-01,4,9,686-9,Ahmadian MR et al,,,0001-09-01,,12509763,Targeting RAS signalling pathways in cancer therapy.,Nature reviews. Cancer,2018-01-01T20:03:00,3,True,2001-11-22,Downward J,,,0001-01-01,,2121370,The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.,Cell,0001-11-16,63,4,843-9,Martin GA et al,,,0001-11-16,
15380,GENE_SUMMARY,,"NF1, a tumor suppressor and negative regulator of RAS, is inactivated by mutation in various cancers. Germline mutations of NF1 are associated with neurofibromatosis type 1 syndrome and juvenile myelomonocytic leukemia.",,2017-04-27,,4763,NF1,neurofibromin 1,False,ENST00000358273,NM_001042492.2,WSS,NFNS,VRNF,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
